ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Clinical trial NCT01909843 · COMPLETED

Trial details

NCT number: NCT01909843
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection

Start date: 2013-07-01
Primary completion: 2013-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.